PDT Partners’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

PDT Partners’s Portfolio MORF Stock Details MORF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-26,474	Closed	-$902K	–	857
2024 Q2	$902K	Sell	26,474 -34,663	-57%	-$1.03M	0.09%	362
2024 Q1	$2.15M	Buy	61,137 +53,535	+704%	+$1.79M	0.2%	181
2023 Q4	$220K	Sell	7,602 -34,640	-82%	-$825K	0.02%	493
2023 Q3	$968K	Buy	42,242 +7,784	+23%	+$408K	0.12%	290
2023 Q2	$1.98M	Buy	+34,458	New	+$1.8M	0.27%	123
2022 Q1	–	Sell	-5,221	Closed	-$247K	–	1154
2021 Q4	$247K	Buy	+5,221	New	+$280K	0.02%	725

Other funds holding MORF

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $693M AUM 34.99% 1-Year Est. Return

PDT Partners's MORF Position: Q3 2024 in Review

PDT Partners sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 26,474 shares — an estimated $902K sold.

PDT Partners first reported a position in MORF in Q4 2021 and held it in 6 quarters. The position peaked at $2.15M in Q1 2024. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

PDT Partners reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
PDT Partners sold 26,474 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $902K.
PDT Partners first reported a position in Morphic Holding, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
PDT Partners's Morphic Holding, Inc. Common Stock position peaked at $2.15M in Q1 2024.
2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on PDT Partners's 13F filing for Q3 2024, filed 14 Nov 2024.